TY - JOUR
T1 - Phenotypes of Recurrent Wheezing in Preschool Children
T2 - Identification by Latent Class Analysis and Utility in Prediction of Future Exacerbation
AU - NIH/NHLBI AsthmaNet
AU - Fitzpatrick, Anne M.
AU - Bacharier, Leonard B.
AU - Guilbert, Theresa W.
AU - Jackson, Daniel J.
AU - Szefler, Stanley J.
AU - Beigelman, Avraham
AU - Cabana, Michael D.
AU - Covar, Ronina
AU - Holguin, Fernando
AU - Lemanske, Robert F.
AU - Martinez, Fernando D.
AU - Morgan, Wayne
AU - Phipatanakul, Wanda
AU - Pongracic, Jacqueline A.
AU - Zeiger, Robert S.
AU - Mauger, David T.
AU - Baxi, Sachin
AU - Benson, Mindy
AU - Blake, Kathryn
AU - Boehmer, Susan
AU - Burnham, Carey Ann
AU - Cabana, Michael
AU - Castro, Mario
AU - Chmiel, James
AU - Daines, Cori
AU - Daines, Michael
AU - Fitzpatrick, Anne
AU - Gaffin, Jonathan
AU - Ann Gentile, Deborah
AU - Gower, W. Adam
AU - Guilbert, Theresa
AU - Israel, Elliot
AU - Jackson, Daniel
AU - Kelly, H. William
AU - Kumar, Harsha Vardhan
AU - Jason Lang, Lang
AU - Lazarus, Stephen
AU - Lima, John
AU - Lemanske, Robert
AU - Ly, Ngoc
AU - Martinez, Fernando
AU - Marbin, Jyothi
AU - Meade, Kelley
AU - Moy, James
AU - Myers, Ross
AU - Olin, Tod
AU - Paul, Ian
AU - Peters, Stephen
AU - Pongracic, Jacqueline
AU - Raissy, Hengameh
N1 - Publisher Copyright:
© 2018 American Academy of Allergy, Asthma & Immunology
PY - 2019/3
Y1 - 2019/3
N2 - Background: Recurrent preschool wheezing is a heterogeneous disorder with significant morbidity, yet little is known about phenotypic determinants and their impact on clinical outcomes. Objective: Latent class analysis (LCA) was used to identify latent classes of recurrent preschool wheeze and their association with future exacerbations and inhaled corticosteroid (ICS) treatment response. Methods: Data from 5 clinical trials of 1708 children aged 12 to 71 months with recurrent wheezing were merged. LCA was performed on 10 demographic, exposure, and sensitization variables to determine the optimal number of latent classes. The primary outcome was the annualized rate of wheezing exacerbations requiring systemic corticosteroids during the study intervention period; the secondary outcome was the time to first exacerbation. Exploratory analyses examined the effect of daily ICS treatment on exacerbation outcomes. Results: Four latent classes of recurrent wheezing were identified; these were not distinguished by current symptoms or historical exacerbations but differed with regard to allergen sensitization and/or exposures. Annualized exacerbation rates (mean ± SEM/year) were 0.65 ± 0.06 for class 1 (“minimal sensitization”), 0.93 ± 0.10 for class 2 (“sensitization with indoor pet exposure”), 0.60 ± 0.07 for class 3 (“sensitization with tobacco smoke exposure”), and 0.81 ± 0.10 for class 4 (“multiple sensitization and eczema”) (P <.001). In a research setting of high adherence, daily ICS treatment improved exacerbation rates in classes 2 and 4 but not the other groups. Conclusions: Sensitization and exposure assessments are useful in the prediction of future exacerbation and may identify children most likely to respond favorably to daily ICS treatment.
AB - Background: Recurrent preschool wheezing is a heterogeneous disorder with significant morbidity, yet little is known about phenotypic determinants and their impact on clinical outcomes. Objective: Latent class analysis (LCA) was used to identify latent classes of recurrent preschool wheeze and their association with future exacerbations and inhaled corticosteroid (ICS) treatment response. Methods: Data from 5 clinical trials of 1708 children aged 12 to 71 months with recurrent wheezing were merged. LCA was performed on 10 demographic, exposure, and sensitization variables to determine the optimal number of latent classes. The primary outcome was the annualized rate of wheezing exacerbations requiring systemic corticosteroids during the study intervention period; the secondary outcome was the time to first exacerbation. Exploratory analyses examined the effect of daily ICS treatment on exacerbation outcomes. Results: Four latent classes of recurrent wheezing were identified; these were not distinguished by current symptoms or historical exacerbations but differed with regard to allergen sensitization and/or exposures. Annualized exacerbation rates (mean ± SEM/year) were 0.65 ± 0.06 for class 1 (“minimal sensitization”), 0.93 ± 0.10 for class 2 (“sensitization with indoor pet exposure”), 0.60 ± 0.07 for class 3 (“sensitization with tobacco smoke exposure”), and 0.81 ± 0.10 for class 4 (“multiple sensitization and eczema”) (P <.001). In a research setting of high adherence, daily ICS treatment improved exacerbation rates in classes 2 and 4 but not the other groups. Conclusions: Sensitization and exposure assessments are useful in the prediction of future exacerbation and may identify children most likely to respond favorably to daily ICS treatment.
UR - http://www.scopus.com/inward/record.url?scp=85055560473&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85055560473&partnerID=8YFLogxK
U2 - 10.1016/j.jaip.2018.09.016
DO - 10.1016/j.jaip.2018.09.016
M3 - Article
C2 - 30267890
AN - SCOPUS:85055560473
SN - 2213-2198
VL - 7
SP - 915-924.e7
JO - Journal of Allergy and Clinical Immunology: In Practice
JF - Journal of Allergy and Clinical Immunology: In Practice
IS - 3
ER -